{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T16:19:10Z","timestamp":1788970750860,"version":"build-2803163510"},"reference-count":38,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,6,28]],"date-time":"2008-06-28T00:00:00Z","timestamp":1214611200000},"content-version":"vor","delay-in-days":58,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The present study aimed to evaluate the effectiveness of 2.5\u00a0mg\/kg\/day cyclosporin (CsA) treatment in patients with severe chronic idiopathic urticaria (CIU) and the impact of CsA treatment on several cytokines involved in the etiopathogenesis of CIU. Twenty\u2010seven CIU patients and 24 healthy control subjects were included in the study. The autologous serum skin test (ASST) for autoantibodies and urticaria activity scoring (UAS) were measured for the evaluation of the clinical severity and the response to therapy, and the serum levels of interleukin (IL)\u20106, IL\u20108, IL\u20102 receptor, IL\u20101\u03b2, tumor necrosis factor (TNF)\u2010\u03b1 and IL\u20105 were measured. The mean UAS score was 32.07\u00a0\u00b1\u00a07.05 and 6.22\u00a0\u00b1\u00a03.84 before and after CsA treatment, respectively. The serum IL\u20102 receptor, TNF\u2010\u03b1 and IL\u20105 levels of patients before CsA treatment were statistically higher than those of the control group (<jats:italic>P<\/jats:italic>\u00a0=\u00a00.001), and after 4\u00a0weeks of CsA therapy the mean IL\u20102R, TNF\u2010\u03b1 and IL\u20105 levels were significantly decreased. The data from this study demonstrate that CsA therapy is efficient and safe for CIU patients. Increase in clinical efficacy and marked decreases in serum cytokine levels suggest that inhibition of cytokine generation is involved in the action of the drug in this clinical setting.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2008.00466.x","type":"journal-article","created":{"date-parts":[[2008,5,12]],"date-time":"2008-05-12T02:23:30Z","timestamp":1210559010000},"page":"276-282","source":"Crossref","is-referenced-by-count":58,"title":["Low\u2010dose and short\u2010term cyclosporine treatment in patients with chronic idiopathic urticaria: A clinical and immunological evaluation"],"prefix":"10.1111","volume":"35","author":[{"given":"H.","family":"SERHAT INALOZ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savas","family":"OZTURK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cenk","family":"AKCALI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Necmettin","family":"KIRTAK","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"TARAKCIOGLU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,28]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.2007.00276.x"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306033282204"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1991.tb03198.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.2500\/aap.2006.27.2875"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1159\/000058004"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(99)70495-0"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02707.x"},{"key":"e_1_2_5_9_2","first-page":"1129","volume-title":"Dermatology in General Medicine","author":"Soter NA","year":"2003"},{"key":"e_1_2_5_10_2","first-page":"431","volume-title":"Dermatology","author":"Braun\u2010Falco O","year":"2005"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2006.01852.x"},{"key":"e_1_2_5_12_2","first-page":"160","volume-title":"Andrews\u2019 Disease of the Skin","author":"Odom RB","year":"2000"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2002.122759"},{"key":"e_1_2_5_14_2","first-page":"283","article-title":"Autologous serum skin test in chronic idiopathic urticaria","volume":"70","author":"Godse KV","year":"2004","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2002.123236"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03588.x"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(94)90360-3"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70506-3"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.144.10.3891"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12499960"},{"key":"e_1_2_5_21_2","first-page":"273","article-title":"Treatment of severe chronic urticaria with cyclosporin A","volume":"3","author":"Barlow RJ","year":"1993","journal-title":"Eur J Dermatol"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199306033282204"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0625.2001.010002128.x"},{"key":"e_1_2_5_24_2","first-page":"136","article-title":"Effect of FK506 and cyclosporin A on cytokin production studied in vitro at single cell level","volume":"75","author":"Andersson J","year":"1992","journal-title":"Immunolgy"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1182\/blood.V81.1.35.35","article-title":"Transcriptional and posttranscriptional regulation of interleukin\u20104 and interleukin\u20103 genes in human T cell","volume":"81","author":"Dokter WH","year":"1993","journal-title":"Blood"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1159\/000236745"},{"key":"e_1_2_5_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70449-3"},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.1999.00958.x"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(97)80025-5"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03664.x"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12338544"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI511"},{"key":"e_1_2_5_33_2","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1997.03890440085013","article-title":"The pathogenesis of chronic idiopathic urticaria","volume":"133","author":"Sabroe RA","year":"1997","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1398-9995.2000.00826.x"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02918819"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2002.04836.x"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1997.tb00996.x"},{"key":"e_1_2_5_38_2","first-page":"285","article-title":"Treatment of chronic idiopathic urticaria and positive autologous serum skin test with cyclosporine: Clinical and immunological evaluation","volume":"24","author":"Di Gioacchino M","year":"2003","journal-title":"Allergy Asthma Proc"},{"key":"e_1_2_5_39_2","first-page":"21","article-title":"The mechanism of action of cyclosporin A in the treatment of chronic urticaria","volume":"3","author":"Vena GA","year":"1997","journal-title":"Semin Clin Immunol"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2008.00466.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2008.00466.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T06:53:53Z","timestamp":1697180033000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2008.00466.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1111\/j.1346-8138.2008.00466.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2008.00466.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}